Three Ways to Slow Down Type 2 Diabetes-Related Brain Aging

Health & Lifestyle
227

Listen to article (english)

Translate to Spanish or other 102 languages!

Type 2 diabetes can affect multiple organ systems in the body—the heart, eyes, kidneys, and even the brain. Image for illustration purposes
Type 2 diabetes can affect multiple organ systems in the body—the heart, eyes, kidneys, and even the brain. Image for illustration purposes

Medical News Today

- Advertisement -

Type 2 diabetes can affect multiple organ systems in the body—the heart, eyes, kidneys, and even the brain. Researchers have also discovered evidence of diabetes leading to faster brain aging, which could increase the risk of Alzheimer’s. But is there a way to prevent this, and how so? In this podcast, we discuss lifestyle interventions that could help slow diabetes-related cognitive decline.

Follow the link below to read the full story on Medical News Today:

https://www.medicalnewstoday.com/articles/3-lifestyle-changes-slow-down-type-2-diabetes-related-brain-aging?slot_pos=article_1&utm_source=Sailthru%20Email&utm_medium=Email&utm_campaign=MNT%20Daily%20News&utm_content=2024-10-10&apid=&rvid=4ba4ec80177cae00eabc43b8bc6648d598c4a356d104663735777e0a0f8b5c9f#1

- Advertisement -

Information Source:  https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
EPA is Requiring the Removal of Lead Pipes in the U.S. 
Next article
Americans are Meeting Minimum Needs for Essential Amino Acids

More Articles

STHS Behavioral’s Summer Mental Health Tips for Kids

STHS Behavioral urges families to prioritize emotional well-being by maintaining routines, encouraging social connections and fostering growth beyond the classroom.

New Insight Into the Iron-Retention Strategies of Colorectal Cancer Cells

Mega Doctor News by Michigan Medicine - University of Michigan Newswise — ANN ARBOR, Michigan...

Study: Weight Loss Drugs Cut Risk of Four Cancers by Half or More

Medical News Today The use of glucagon-like peptide-1 (GLP-1) receptor agonistTrusted Source medications continues...

FDA Approves Expanded Use of Kidney Cancer Treatment Rooted in UTSW Discovery

Belzutifan, a first-in-class drug that arose from scientific discoveries at UT Southwestern Medical Center, has been approved by the Food and Drug Administration to treat some patients with earlier stage kidney cancers in combination with an immunotherapy drug. This move marks the latest expansion of belzutifan’s indications after it was originally approved in 2021.
- Advertisement -